# Efficacy, Safety of Solution Containing Hyperosmolar Sodium Lactate Infusion for Resuscitation of Patients With Hemorrhagic Shock

> **NCT01433276** · PHASE3 · COMPLETED · sponsor: **Innogene Kalbiotech Pte. Ltd** · enrollment: 71 (actual)

## Conditions studied

- Hemorrhagic Shock

## Interventions

- **DRUG:** Hyperosmolar sodium lactate
- **DRUG:** Ringer's lactate

## Key facts

- **NCT ID:** NCT01433276
- **Lead sponsor:** Innogene Kalbiotech Pte. Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2011-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01433276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01433276, "Efficacy, Safety of Solution Containing Hyperosmolar Sodium Lactate Infusion for Resuscitation of Patients With Hemorrhagic Shock". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01433276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*